Lung Cancer Study Day
Join us on the 24th March 2026 for the Lung Cancer Study Day. This event is Hybrid Overview This multidisciplinary educational event brings together renowned healthcare professionals to explore the […]
Pioneering cancer team recognised for improving cancer treatment and care across the Tees Valley
Health professionals from Teesside are celebrating after scooping a regional award for their commitment to getting patients home quicker following lung surgery. The thoracic surgical service at University Hospitals Tees […]
New drug shows dramatic effect in shrinking lung cancer tumours
A new drug is having a dramatic effect on shrinking lung cancer tumours, according to new research. A trial testing the drug zongertinib as a first treatment for people with […]
Award for life-saving cancer screening team
A team who have invited more than 30,000 people for life-saving cancer checks have won an award for their work. The lung cancer screening team, based at Buckland Hospital in […]
Lung Cancer Europe’s 10th report exposes deep emotional toll of lung cancer across 31 countries
Lung Cancer Europe has launched the largest global survey to date on the psychological and emotional impact of lung cancer, drawing on responses from 2,204 people across 31 countries. The […]
NICE recommends lung cancer treatment, Lorviqua®q (lorlatinib), at first line, in final draft guidance
Pfizer Ltd announced today that the National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending Lorviqua®q (lorlatinib) as an option for anaplastic lymphoma kinase (ALK)-positive […]
New service in Bridgwater aims to help detect lung cancer earlier
Patients in Bridgwater are now able to self-refer for a chest x-ray to help detect lung cancer earlier. The Somerset Chest X-Ray Service launched this summer and means patients aged […]
First UK patient recruited for pioneering lung cancer drug trial at UHNM
The University Hospitals of North Midlands NHS Trust has become the first NHS Trust in the UK to successfully recruit a patient onto a major new international small-cell lung cancer […]
HCA Healthcare UK delivers pioneering TIL therapy in clinical trial for patient with metastatic lung cancer
Leading private healthcare provider HCA Healthcare UK has announced that it has treated a metastatic lung cancer patient with tumour-infiltrating lymphocyte (TIL) therapy for the first time as part of […]
UK Lung Cancer Coalition – UK Lung Cancer: 20 years on – what’s next?
UK Lung Cancer: 20 years on – what’s next? 4th November, Mary Ward House, London Join the UK Lung Cancer Coalition (UKLCC) at its 20th anniversary conference. Not only will […]
